{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:10:39Z","timestamp":1778944239363,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,20]]},"DOI":"10.7759\/cureus.36428","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T20:28:27Z","timestamp":1679344107000},"source":"Crossref","is-referenced-by-count":4,"title":["An Unusual Cause of Persistent Tachycardia: Atypical Neuroleptic Malignant Syndrome"],"prefix":"10.7759","author":[{"given":"Sanchit","family":"Duhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijeta","family":"Keisham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anubhav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v09n0211b","article-title":"Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report","volume":"9","author":"Molina D","year":"2007","unstructured":"Molina D, Tingle LE, Lu X. Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report. Prim Care Companion J Clin Psychiatry. 2007, 9:148-50. 10.4088\/pcc.v09n0211b","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto S","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005, 10:79-104. 10.1038\/sj.mp.4001556","journal-title":"Mol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/MJDRDYPU.MJDRDYPU_101_20","article-title":"A case of aripiprazole-induced neuroleptic malignant syndrome","volume":"14","author":"Ramdurg S","year":"2021","unstructured":"Ramdurg S, Chaukimath S, Manovijay B. A case of aripiprazole-induced neuroleptic malignant syndrome.  Med. J. DY Patil Univ. 2021, 14:712. 10.4103\/MJDRDYPU.MJDRDYPU_101_20","journal-title":"Med. J. DY Patil Univ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000944","article-title":"Aripiprazole induced late neuroleptic malignant syndrome","volume":"26","author":"Agrawal A","year":"2019","unstructured":"Agrawal A, Bajaj D, Bajaj S, Mattana J. Aripiprazole induced late neuroleptic malignant syndrome. Am J Ther. 2019, 26:e772-3. 10.1097\/MJT.0000000000000944","journal-title":"Am J Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9037-17","article-title":"\"Brief\" aripiprazole-induced neuroleptic malignant syndrome with symptoms that only lasted a few hours","volume":"56","author":"Mizumura N","year":"2017","unstructured":"Mizumura N, Uematsu M, Ito A, Okumura S, Maehira H, Ogawa M, Kawasaki M. \"Brief\" aripiprazole-induced neuroleptic malignant syndrome with symptoms that only lasted a few hours. Intern Med. 2017, 56:3089-92. 10.2169\/internalmedicine.9037-17","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis","volume":"15","author":"Belvederi Murri M","year":"2015","unstructured":"Belvederi Murri M, Guaglianone A, Bugliani M, et al.. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D. 2015, 15:45-62. 10.1007\/s40268-014-0078-0","journal-title":"Drugs R D"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02597-x","article-title":"Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report","volume":"20","author":"Szota AM","year":"2020","unstructured":"Szota AM, Radajewska I, Grudzka P, Araszkiewicz A. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC Psychiatry. 2020, 20:179. 10.1186\/s12888-020-02597-x","journal-title":"BMC Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17l02218","article-title":"Neuroleptic malignant syndrome: the value of diagnostic criteria","volume":"20","author":"Rowland TA","year":"2018","unstructured":"Rowland TA, Banga A, Ayadurai N. Neuroleptic malignant syndrome: the value of diagnostic criteria. Prim Care Companion CNS Disord. 2018, 20:17l02218. 10.4088\/PCC.17l02218","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312438215","article-title":"Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case Register","volume":"2","author":"Chang CK","year":"2012","unstructured":"Chang CK, Harrison S, Lee W, Taylor D, Stewart R. Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case Register. Ther Adv Psychopharmacol. 2012, 2:75-83. 10.1177\/2045125312438215","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-10401-6_15","article-title":"Special syndromes: serotonin syndrome, neuroleptic malignant syndrome, and catatonia","author":"Kulikowski J","year":"2019","unstructured":"Kulikowski J, Parthasarathi U. Special syndromes: serotonin syndrome, neuroleptic malignant syndrome, and catatonia. Inpatient Geriatric Psychiatry. Fenn H, Hategan A, Bourgeois J (ed): Springer, Cham, 2019. 771:277-92. 10.1007\/978-3-030-10401-6_15"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1186\/s43045-020-00081-6","article-title":"Neuroleptic malignant syndrome: clinical expression, complication, course, and atypical clinical picture","volume":"28","author":"Oneib B","year":"2021","unstructured":"Oneib B, Zaimi O. Neuroleptic malignant syndrome: clinical expression, complication, course, and atypical clinical picture. Middle East Curr Psychiatry. 2021, 28:1.","journal-title":"Middle East Curr Psychiatry"},{"key":"ref12","article-title":"Neuroleptic malignant syndrome","author":"Simon LV","year":"2022","unstructured":"Simon LV, Hashmi MF, Callahan AL. Neuroleptic malignant syndrome. StatPearls. StatPearls Publishing, Treasure Island (FL); 2022."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144741-an-unusual-cause-of-persistent-tachycardia-atypical-neuroleptic-malignant-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:05Z","timestamp":1707508625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144741-an-unusual-cause-of-persistent-tachycardia-atypical-neuroleptic-malignant-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.36428","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}